… The main objective of the present study was to discover new molecular entity that acts as a Top1 poison with improved efficacy. We initiated our study by pharmacophoremodeling and …
R Arora, U Issar, R Kakkar - Journal of Biomolecular Structure and …, 2018 - Taylor & Francis
… to our proposed pharmacophoremodel. For moleculardocking, the protein and the ligands to be docked should be in the appropriate conformations. As the protein, acetohydroxamate-…
P Kaushik, S Lal Khokra, AC Rana… - Advances in …, 2014 - Wiley Online Library
… generations of the pharmacophoremodel which predicts Tyr48 … In our moleculardocking simulation on 1US0, we found that … ; this data is well correlated with the pharmacophoremodel. …
KR Valasani, JR Vangavaragu, VW Day… - … and modeling, 2014 - ACS Publications
… Our previous use of 2D QSAR, 3D pharmacophoremodels, and moleculardocking experiments to successfully predict activity indicates that this can be a very powerful technique for …
CL Lu, L Zhou, ZC Li, X Gao, W Zhang - Medicinal Chemistry Research, 2012 - Springer
… The best pharmacophoremodel was used as a 3D … PharmacophoreMapping protocol. The compounds which fitted all the pharmacophore features of the best pharmacophoremodel …
A Barakat, AM Al-Majid, BM Al-Qahtany, M Ali… - Chemistry Central …, 2018 - Springer
… dimedone in a single molecular framework were designed and synthesized. We subjected our target compounds to pharmacophoremodeling and moleculardocking on different target …
J Vora, S Patel, M Athar, S Sinha… - Journal of …, 2019 - Taylor & Francis
… In particular, combined pharmacophoremapping and moleculardocking were used to … 3D-QSAR pharmacophoremodeling. Interaction between proteins, namely, envelope G protein, …
… The Docking takes all the information from a rigid protein … docking programs available for moleculardockingstudies. In … Optimisation for Ligand Docking), a docking program [36] …
MO Idris, AA Yekeen, OS Alakanse… - Journal of Biomolecular …, 2021 - Taylor & Francis
… In this study, we developed a pharmacophoremodel of reportedly potent drugs against severe acute respiratory syndrome coronaviruses 1 and 2 (SARS-CoV-1 and -2). The model was …